Brief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
May 8 (Reuters) - Initiator Pharma A/S INIT.ST: Q1 2026 NET REVENUE WAS KDKK 0 Q1 2026 OPERATING LOSS, EBIT WAS KDKK -11,432 Source text: ID:nMFNfbSRw Further company coverage: INIT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD